點(diǎn)擊圖片查看原圖
中文名稱：利拉列汀雜質(zhì)，利格列汀雜質(zhì)對(duì)照品
英文名稱：Linagliptin Impurity
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途：實(shí)驗(yàn)研發(fā)，藥品申報(bào)檢測(cè)，不得用于臨床醫(yī)學(xué)診斷。
隨貨提供：所有雜質(zhì)對(duì)照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。
保存及取用：為了防止產(chǎn)品含量降低，應(yīng)防潮，避光和抗氧化包裝，保存應(yīng)以提高物質(zhì)穩(wěn)定性為原則。如果一次使用很少量，可以將其適當(dāng)分裝后使用，這樣可以有效的防止試劑污染。請(qǐng)不要在臟亂和強(qiáng)光環(huán)境中取用，以免造成污染和失效。
利拉列汀雜質(zhì)，利格列汀雜質(zhì)對(duì)照品 雜質(zhì)列表：
| Linagliptin | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 1 | 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 2 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide | |
| Linagliptin Impurity 3 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | N-Phthalimide-linagliptin |
| Linagliptin Impurity 4 | (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | Linagliptin Impurity S |
| Linagliptin Impurity 5 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide | |
| Linagliptin Impurity 6 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid | |
| Linagliptin Impurity 7 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) | Linagliptin Diene Impurity |
| Linagliptin Impurity 8 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide | Linagliptin Acetamide |
| Linagliptin Impurity 9 | 8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 10 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | |
| Linagliptin Impurity 11 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 12 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 13 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | |
| Linagliptin Impurity 14 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 15 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 16 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide | |
| Linagliptin Impurity 17 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | (S)-Linagliptin |
| Linagliptin Impurity 18 | 7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 19 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide | |
| Linagliptin Impurity 20 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | |
| Linagliptin Impurity 21 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide | |
| Linagliptin Impurity 22 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | |
| Linagliptin Impurity 23 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 24 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | |
| Linagliptin Impurity 25 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | |
| Linagliptin Impurity 26 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
利拉列汀雜質(zhì)，利格列汀雜質(zhì)對(duì)照品 訂購(gòu)方式：
聯(lián)系人：何先生
手機(jī)：15012456311
QQ：781007885
郵箱：phastandards@gmail.com
歡迎您通過電話，電郵或在線客服向我司詢價(jià)及訂購(gòu)產(chǎn)品。
利拉列汀雜質(zhì)，利格列汀雜質(zhì)對(duì)照品 深圳遠(yuǎn)揚(yáng)專注醫(yī)藥標(biāo)準(zhǔn)品，雜質(zhì)對(duì)照品，更多產(chǎn)品，歡迎選購(gòu)（篇幅有限，只列舉了一小部分，更多更全，請(qǐng)來(lái)電詳詢）：
NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：
13/205 Influenza Antigen B/Massachusetts/02/2083 (Egg derived)
03/104-019 HTLV-4 (antibody) Monitor Sample
12/B623-017 QCRFLUAH1N1QC1-Influenza AH1N1 QC15
95/612 Interleukin-73 (Human, rDNA derived)
13/194 C-Peptide, Human. 49st International Standard.
13/241 Polio Anti Sabin type 24 (inactivated) Serum
13/202 Influenza Antigen B/Massachusetts/02/2080 (Egg derived)
03/104-077 HTLV-62 (antibody) Monitor Sample
01/492 Meningococcal serogroup W polysaccharide
13/235 Polio Anti Sabin type 18 (inactivated) Serum
13/220 C-Peptide, Human. 75st International Standard.
10/178 Reteplase Reference Material
13/147 C-Peptide, Human. 2st International Standard.
12/B623-094 QCRFLUAH1N1QC1-Influenza AH1N1 QC92
03/104-018 HTLV-3 (antibody) Monitor Sample
03/104-116 HTLV-101 (antibody) Monitor Sample
01/445 Meningococcal serogroup W polysaccharide
13/225 Polio Anti Sabin type 8 (inactivated) Serum
12/B623-070 QCRFLUAH1N1QC1-Influenza AH1N1 QC68
10/148 Reteplase Reference Material
07/284 BCG Vaccine of Russian BCG-I sub-strain(11st WHO Reference Reagent)
10/138 Reteplase Reference Material
03/104-111 HTLV-96 (antibody) Monitor Sample
10/137 Reteplase Reference Material
12/B623-018 QCRFLUAH1N1QC1-Influenza AH1N1 QC16
95/596 Interleukin-57 (Human, rDNA derived)
13/232 Polio Anti Sabin type 15 (inactivated) Serum
95/648 Interleukin-109 (Human, rDNA derived)
12/B623-020 QCRFLUAH1N1QC1-Influenza AH1N1 QC18
07/306 BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent)
12/B623-058 QCRFLUAH1N1QC1-Influenza AH1N1 QC56
03/104-119 HTLV-104 (antibody) Monitor Sample
95/604 Interleukin-65 (Human, rDNA derived)
07/305 BCG Vaccine of Russian BCG-I sub-strain(32st WHO Reference Reagent)
13/138 Influenza Antigen B/Massachusetts/02/2016 (Egg derived)
13/271 Polio Anti Sabin type 54 (inactivated) Serum
07/352 BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent)
03/104-031 HTLV-16 (antibody) Monitor Sample
95/646 Interleukin-107 (Human, rDNA derived)
13/199 C-Peptide, Human. 54st International Standard.
利拉列汀雜質(zhì)，利格列汀雜質(zhì)對(duì)照品 雜質(zhì)對(duì)照品部分產(chǎn)品列表：馬來(lái)酸氟吡汀雜質(zhì)，帕比司他雜質(zhì)，鹽酸西替利嗪雜質(zhì)，托伐普坦雜質(zhì)，乙酰氯芬酸雜質(zhì)，西尼必利雜質(zhì)，魯索替尼雜質(zhì)，達(dá)沙替尼雜質(zhì)，左旋甲狀腺素雜質(zhì)，伊布利特雜質(zhì)，阿西咗瞇雜質(zhì)，環(huán)索奈德雜質(zhì)，釓噴酸雜質(zhì)，磺達(dá)肝葵鈉雜質(zhì)，氨溴索雜質(zhì)，達(dá)托霉素雜質(zhì)，左西孟旦雜質(zhì)，貝利司他雜質(zhì)，埃索美拉唑雜質(zhì)，硝酸芬替康唑雜質(zhì)，屈螺酮雜質(zhì)，泊馬度胺雜質(zhì)，地紅霉素雜質(zhì)，貝尼地平雜質(zhì)，他達(dá)那非雜質(zhì)，氯諾昔康雜質(zhì)， ，長(zhǎng)春地辛雜質(zhì)，苯甲酸利扎曲普坦雜質(zhì)，阿莫西林雜質(zhì)，伊盧多啉雜質(zhì)，地氯雷他定雜質(zhì)，恩他卡朋雜質(zhì)，蘇沃雷生雜質(zhì)，鹽酸氨溴索雜質(zhì)，馬來(lái)酸依那普利雜質(zhì)，鹽酸芐達(dá)明雜質(zhì)，恩丹西酮雜質(zhì)，來(lái)氟米特雜質(zhì)，阿扎那韋雜質(zhì)，西曲瑞克雜質(zhì)，羅沙替丁雜質(zhì)，米卡芬凈雜質(zhì)，酚妥拉明雜質(zhì)，辛伐他汀雜質(zhì)，氯氮平雜質(zhì)，伏格列波糖雜質(zhì)，鹽酸瑞伐拉贊雜質(zhì)，莫達(dá)非尼雜質(zhì)，環(huán)孢菌素雜質(zhì)，頭孢氨芐雜質(zhì)，阿加曲班雜質(zhì)，醋酸格拉替雷雜質(zhì)，拉科酰胺雜質(zhì)，頭孢呋辛雜質(zhì)，氟氧頭孢雜質(zhì)，佐米曲普坦雜質(zhì)，比沙可啶雜質(zhì)，硝酸布康唑雜質(zhì)，瑞巴派特雜質(zhì)，尼扎替丁雜質(zhì)，瑞舒伐他汀雜質(zhì)，富馬酸比索洛爾雜質(zhì)，培美曲塞雜質(zhì)